Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Bimagrumab> ?p ?o. }
Showing items 1 to 23 of
23
with 100 items per page.
- Bimagrumab abstract "Bimagrumab (BYM338) is a human monoclonal antibody developed by Novartis to treat pathological muscle loss and weakness. On August 20, 2013 it was announced that bimagrumab was granted breakthrough therapy designation for sporadic inclusion body myositis (sIBM) by US Food and Drug Administration.".
- Bimagrumab atcPrefix "none".
- Bimagrumab casNumber "1356922-05-8".
- Bimagrumab wikiPageID "40294938".
- Bimagrumab wikiPageRevisionID "588833234".
- Bimagrumab atcPrefix "none".
- Bimagrumab casNumber "1356922".
- Bimagrumab chemspiderid "NA".
- Bimagrumab source "u".
- Bimagrumab target ACVR2B.
- Bimagrumab type "mab".
- Bimagrumab subject Category:Disorders_of_muscles.
- Bimagrumab subject Category:Monoclonal_antibodies.
- Bimagrumab subject Category:Novartis.
- Bimagrumab type Drug.
- Bimagrumab type FunctionalSubstance.
- Bimagrumab comment "Bimagrumab (BYM338) is a human monoclonal antibody developed by Novartis to treat pathological muscle loss and weakness. On August 20, 2013 it was announced that bimagrumab was granted breakthrough therapy designation for sporadic inclusion body myositis (sIBM) by US Food and Drug Administration.".
- Bimagrumab label "Bimagrumab".
- Bimagrumab sameAs m.0wxy8jm.
- Bimagrumab sameAs Q15708291.
- Bimagrumab sameAs Q15708291.
- Bimagrumab wasDerivedFrom Bimagrumab?oldid=588833234.
- Bimagrumab isPrimaryTopicOf Bimagrumab.